Allarity shares rise 10.20% intraday after completing $2.5M private placement to boost working capital.

Allarity Therapeutics surged 10.20% intraday after completing a private placement that raised $2.5 million in September 2025 and an additional $250,000 in December 2025. The fundraising, aimed at bolstering working capital, was likely viewed favorably by investors as a sign of the company’s ability to secure financing for operational needs. The intraday price jump aligns with the news, suggesting market confidence in the capital infusion to support ongoing activities.